22369755|t|Reciprocal effects of NNK and SLURP-1 on oncogene expression in target epithelial cells.
22369755|a|AIMS: To elucidate how the nicotinic acetylcholine receptors expressed on bronchial and oral epithelial cells targeted by the tobacco nitrosamine (4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone) (NNK) facilitate carcinogenic transformation. MAIN METHODS: Since NNK-dependent transformation can be abolished by the nicotinergic secreted mammalian Ly-6/urokinase plasminogen activator receptor related protein-1 (SLURP-1), we compared effects of NNK and recombinant (r)SLURP-1 on the expression of genes related to tumorigenesis in human immortalized bronchial and oral epithelial cell lines BEP2D and Het-1A, respectively. KEY FINDINGS: NNK stimulated expression of oncogenic genes, including MYB and PIK3CA in BEP2D, ETS1, NRAS and SRC in Het-1A, and AKT1, KIT and RB1 in both cell types, which could be abolished in the presence of rSLURP-1. Other cancer-related genes whose upregulation by NNK was abolishable by rSLURP-1 were the growth factors EGF in BEP2D cells and HGF in Het-1A cells, and the transcription factors CDKN2A and STAT3 (Het-1A only). NNK also upregulated the anti-apoptotic BCL2 (Het-1A) and downregulated the pro-apoptotic TNF (Het-1A), BAX and CASP8 (BEP2D), all of which could be abolished, in part, by rSLURP-1. NNK decreased expression of the CTNNB1 gene encoding the intercellular adhesion molecule beta-catenin (BEP2D), as well as tumor suppressors CDKN3 and FOXD3 in BEP2D cells and SERPINB5 in Het-1A cells. These pro-oncogenic effects of NNK were abolished by rSLURP-1 that also upregulated RUNX3. SIGNIFICANCE: The obtained results identified target genes for both NNK and SLURP-1 and shed light on the molecular mechanism of their reciprocal effects on tumorigenic transformation of bronchial and oral epithelial cells.
22369755	22	25	NNK	ChemicalEntity	C016583
22369755	30	37	SLURP-1	GeneOrGeneProduct	57152
22369755	116	149	nicotinic acetylcholine receptors	GeneOrGeneProduct	1136
22369755	215	222	tobacco	OrganismTaxon	4097
22369755	223	234	nitrosamine	ChemicalEntity	D009602
22369755	236	282	4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone	ChemicalEntity	C016583
22369755	285	288	NNK	ChemicalEntity	C016583
22369755	301	313	carcinogenic	DiseaseOrPhenotypicFeature	D009369
22369755	350	353	NNK	ChemicalEntity	C016583
22369755	435	498	Ly-6/urokinase plasminogen activator receptor related protein-1	GeneOrGeneProduct	57152
22369755	500	507	SLURP-1	GeneOrGeneProduct	57152
22369755	533	536	NNK	ChemicalEntity	C016583
22369755	556	563	SLURP-1	GeneOrGeneProduct	57152
22369755	602	615	tumorigenesis	DiseaseOrPhenotypicFeature	D009369
22369755	619	624	human	OrganismTaxon	9606
22369755	679	684	BEP2D	CellLine	CVCL_6E77
22369755	689	695	Het-1A	CellLine	CVCL_3702
22369755	725	728	NNK	ChemicalEntity	C016583
22369755	781	784	MYB	GeneOrGeneProduct	4602
22369755	789	795	PIK3CA	GeneOrGeneProduct	5290
22369755	799	804	BEP2D	CellLine	CVCL_6E77
22369755	806	810	ETS1	GeneOrGeneProduct	2113
22369755	812	816	NRAS	GeneOrGeneProduct	4893
22369755	821	824	SRC	GeneOrGeneProduct	6714
22369755	828	834	Het-1A	CellLine	CVCL_3702
22369755	840	844	AKT1	GeneOrGeneProduct	207
22369755	846	849	KIT	GeneOrGeneProduct	3815
22369755	854	857	RB1	GeneOrGeneProduct	5925
22369755	922	930	rSLURP-1	GeneOrGeneProduct	57152
22369755	938	944	cancer	DiseaseOrPhenotypicFeature	D009369
22369755	981	984	NNK	ChemicalEntity	C016583
22369755	1004	1012	rSLURP-1	GeneOrGeneProduct	57152
22369755	1037	1040	EGF	GeneOrGeneProduct	1950
22369755	1044	1049	BEP2D	CellLine	CVCL_6E77
22369755	1060	1063	HGF	GeneOrGeneProduct	3082
22369755	1067	1073	Het-1A	CellLine	CVCL_3702
22369755	1111	1117	CDKN2A	GeneOrGeneProduct	1029
22369755	1122	1127	STAT3	GeneOrGeneProduct	6774
22369755	1129	1135	Het-1A	CellLine	CVCL_3702
22369755	1143	1146	NNK	ChemicalEntity	C016583
22369755	1183	1187	BCL2	GeneOrGeneProduct	596
22369755	1189	1195	Het-1A	CellLine	CVCL_3702
22369755	1233	1236	TNF	GeneOrGeneProduct	7124
22369755	1238	1244	Het-1A	CellLine	CVCL_3702
22369755	1247	1250	BAX	GeneOrGeneProduct	581
22369755	1255	1260	CASP8	GeneOrGeneProduct	841
22369755	1262	1267	BEP2D	CellLine	CVCL_6E77
22369755	1315	1323	rSLURP-1	GeneOrGeneProduct	57152
22369755	1325	1328	NNK	ChemicalEntity	C016583
22369755	1357	1363	CTNNB1	GeneOrGeneProduct	1499
22369755	1414	1426	beta-catenin	GeneOrGeneProduct	1499
22369755	1428	1433	BEP2D	CellLine	CVCL_6E77
22369755	1447	1452	tumor	DiseaseOrPhenotypicFeature	D009369
22369755	1465	1470	CDKN3	GeneOrGeneProduct	1033
22369755	1475	1480	FOXD3	GeneOrGeneProduct	27022
22369755	1484	1489	BEP2D	CellLine	CVCL_6E77
22369755	1500	1508	SERPINB5	GeneOrGeneProduct	5268
22369755	1512	1518	Het-1A	CellLine	CVCL_3702
22369755	1557	1560	NNK	ChemicalEntity	C016583
22369755	1579	1587	rSLURP-1	GeneOrGeneProduct	57152
22369755	1610	1615	RUNX3	GeneOrGeneProduct	864
22369755	1685	1688	NNK	ChemicalEntity	C016583
22369755	1693	1700	SLURP-1	GeneOrGeneProduct	57152
22369755	1774	1785	tumorigenic	DiseaseOrPhenotypicFeature	D009369
22369755	Association	5268	D009369	Novel
22369755	Association	27022	D009369	Novel
22369755	Association	1033	D009369	Novel
22369755	Association	D009369	6774	Novel
22369755	Association	D009369	1029	Novel
22369755	Association	D009369	3082	Novel
22369755	Association	D009369	1950	Novel
22369755	Positive_Correlation	5925	C016583	Novel
22369755	Positive_Correlation	3815	C016583	Novel
22369755	Positive_Correlation	207	C016583	Novel
22369755	Positive_Correlation	6714	C016583	Novel
22369755	Positive_Correlation	4893	C016583	Novel
22369755	Positive_Correlation	2113	C016583	Novel
22369755	Positive_Correlation	57152	864	Novel
22369755	Association	57152	D009369	Novel
22369755	Positive_Correlation	C016583	864	Novel
22369755	Negative_Correlation	C016583	5268	Novel
22369755	Negative_Correlation	C016583	27022	Novel
22369755	Negative_Correlation	C016583	1033	Novel
22369755	Negative_Correlation	C016583	1499	Novel
22369755	Negative_Correlation	C016583	841	Novel
22369755	Negative_Correlation	C016583	581	Novel
22369755	Negative_Correlation	C016583	7124	Novel
22369755	Positive_Correlation	C016583	596	Novel
22369755	Positive_Correlation	C016583	6774	Novel
22369755	Positive_Correlation	C016583	1029	Novel
22369755	Positive_Correlation	C016583	3082	Novel
22369755	Positive_Correlation	C016583	1950	Novel
22369755	Association	C016583	D009369	Novel
22369755	Positive_Correlation	C016583	5290	Novel
22369755	Positive_Correlation	C016583	4602	Novel
22369755	Negative_Correlation	C016583	57152	Novel